A simple question about peanut allergies led Dr. Gideon Lack to a discovery that would change the way the world understands food allergies. What began as curiosity turned into decades of research that reshaped medical advice for millions of parents.
The question that started a revolution
When Dr. Gideon Lack stood before an audience of allergists and pediatricians years ago, he asked what seemed like a straightforward question: how many of them had treated a child with a peanut allergy? In most countries, nearly every hand would go up. Peanut allergies had become one of the most common—and frightening—childhood conditions, affecting about two percent of children in the United States and showing similar numbers in the United Kingdom.
But when Lack posed the same question at a conference in Tel Aviv, only a handful of doctors raised their hands. Out of around two hundred professionals, barely three had treated such a case. The discrepancy baffled him. Jewish children in London, who shared similar genetic backgrounds with those in Israel, showed much higher rates of peanut allergy. What, then, explained this dramatic difference?
That perplexing incident launched Lack on an odyssey that would stretch over fifteen years and ultimately dismantle one of medicine’s most firmly established convictions regarding allergy avoidance.
Unveiling an unforeseen trend
The answer, as Lack later found, was hiding in plain sight. While spending time in Israel, he noticed something unique about local eating habits. Parents routinely fed their babies “Bamba,” a popular peanut-flavored puff snack, as early as four to six months of age. The product contained significant amounts of peanut protein, and Israeli children consumed it regularly and enthusiastically.
In contrast, parents in the United Kingdom were being instructed to do the precise opposite: to refrain from introducing peanuts or other potential allergens to their babies until they reached an age of several years. The reasoning behind this recommendation appeared logical at the time—if a particular food had the potential to cause allergies, then perhaps postponing its introduction would avert sensitization. However, the remarkably low incidence of peanut allergies observed in Israeli children indicated that this long-held strategy could be entirely mistaken.
Curious, Lack and his team compared the diets of around 10,000 children—half in Israel and half in London—who shared similar ancestry. The results were undeniable: peanut allergies were almost ten times more common among the British group. The only clear difference was when peanuts were introduced into the diet. Israeli babies were consuming the equivalent of ten peanuts a week by their first birthday, while British babies had virtually none.
Although the discovery was intriguing, it remained an observation. To transform a correlation into definitive proof, Lack required stringent scientific validation.
Questioning long-standing medical recommendations
At that juncture, the concept of intentionally introducing peanuts to babies appeared nearly irresponsible. Numerous medical professionals and guardians feared that such a method would trigger allergic responses instead of averting them. Funding bodies were reluctant, and significant ethical issues were prevalent. Despite this, Lack persevered.
In 2008, backed by the U.S. National Institutes of Health, his group initiated a substantial, meticulously managed investigation known as the LEAP trial (Learning Early About Peanut Allergy). This study concentrated on babies who faced an elevated risk of developing allergies due to severe eczema or pre-existing egg allergies. The infants were randomly assigned to one of two cohorts: one group was to completely abstain from peanuts, while the other was prompted to consume small quantities of peanut-derived foods consistently, starting as early as four months old.
Recruiting the 640 participants took two years, and the study followed them for five. The results, when they arrived, were astonishing. Among the children who avoided peanuts, nearly 14% developed peanut allergies by the age of five. In the group that consumed peanuts early, the number dropped to less than 2%. Even among children who had shown early signs of sensitivity, regular peanut consumption cut the risk of developing a full-blown allergy by more than two-thirds.
The information showed a decrease of more than 80% in peanut allergy occurrences for individuals who were exposed to peanuts at an early age—a significant discovery that completely altered previous medical recommendations.
From initial insight to complete metamorphosis
When the LEAP study’s findings were published in 2015 in The New England Journal of Medicine, they marked a turning point in allergy research and pediatric nutrition. For years, official guidelines had recommended delaying exposure to allergenic foods. Now, the evidence was clear: early introduction, not avoidance, was the key to building tolerance.
The implications were enormous. The American Academy of Pediatrics, which had once advised parents to wait until age three before introducing peanuts, reversed its stance. Updated guidelines issued in 2017 encouraged introducing peanut-containing foods as early as four to six months for most babies.
The effects of this change were swift and measurable. A 2024 study published in Pediatrics found that peanut allergy rates among U.S. children under age three had dropped by more than 40% since the new guidelines took effect. That translates to tens of thousands of children avoiding what had once been a lifelong and potentially life-threatening allergy.
The ongoing evolution of medical understanding
For Dr. Lack, the experience was both humbling and affirming. He admitted that, like many other doctors, he had once followed the avoidance strategy with his own children. Yet he also emphasized that the winding, self-correcting nature of science is what ultimately drives progress.
“The history of medicine is a series of zigzags,” he explained. “We make recommendations based on the best knowledge we have, and when the evidence changes, so should we.”
That philosophy continues to guide his research. Today, Lack co-leads a new project known as the SEAL study, once again challenging traditional assumptions. This time, the focus is on the connection between eczema and food allergies.
For years, doctors believed that food allergies triggered eczema. Now, evidence suggests the relationship works in reverse: babies who develop eczema early may be more likely to later develop food allergies. The SEAL study aims to test whether aggressively treating eczema in the first weeks of life—using moisturizers and mild topical treatments—could prevent allergies from developing in the first place.
The science behind early exposure
The core idea behind this novel investigation is termed the “dual-exposure hypothesis.” This theory suggests that the manner in which the immune system encounters food proteins dictates whether it identifies them as harmless or threatening. When an infant consumes food, exposure via the digestive tract instructs the immune system to accept it. However, exposure through compromised or inflamed skin, a common occurrence with eczema, could yield the opposite outcome, fostering sensitization and allergic responses.
Dr. David Hill, a pediatric allergist at the Children’s Hospital of Philadelphia and a fellow researcher in this field, characterized the immune system as a guardian. He stated, “When infants consume foods early, their immune system recognizes these proteins as benign.” He further added, “However, if those identical proteins enter the body via compromised skin, the immune system might misinterpret them as dangers.”
Lack frequently illustrates the concept using a metaphor: “Should I politely tap on your front door and request entry, you’d likely extend a courteous welcome. However, if I were to smash through a window, your reaction would undoubtedly differ.”
If the SEAL investigation validates this hypothesis, it has the potential to revolutionize not only the avoidance of allergies but also global pediatric dermatological and dietary approaches.
Redefining how we think about allergies
The progression from that initial presentation in Tel Aviv to the contemporary comprehension of preventing food allergies illustrates how scientific breakthroughs can overturn established beliefs. What started as a localized point of interest evolved into one of the most impactful transformations in pediatric healthcare in recent times.
Dr. Lack’s contributions have already transformed the experiences of numerous households. Previously, parents were advised to steer clear of peanuts due to apprehension; however, they are now prompted to introduce them early and securely, frequently with pediatric oversight. This research has also spurred additional investigations into other allergenic foods, ranging from eggs to tree nuts, indicating that early exposure might broadly diminish the worldwide prevalence of allergies.
For Lack and his colleagues, the goal has never been merely to publish findings but to create real-world change. As he often reminds his audiences, science advances not by being perfect but by being willing to admit when it’s wrong. The key, he believes, is staying open to evidence, even when it contradicts everything we thought we knew.
From the joyful sounds of Israeli infants enjoying Bamba to the subsequent laboratory investigations, the narrative of preventing peanut allergies exemplifies perseverance, modesty, and the impact of challenging preconceived notions. It serves as a reminder that in scientific endeavors, much like in life, advancement seldom follows a direct path—yet each new finding propels us nearer to comprehension, recovery, and prophylaxis.
